/Companies

Novel Bio

1 known investors

Find your way into Novel Bio

Sign up to see every warm intro you have to Novel Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Novel Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Novel Bio is a US-based contract development and manufacturing organization (CDMO) that produces R&D, High-Quality, and GMP-grade plasmid DNA using optimized E. coli platforms. It serves biotech and pharmaceutical developers working on nucleic acid vaccines, RNA therapeutics, and cell and gene therapies, offering domestic plasmid supply aligned with BIOSECURE Act requirements.

Investors · 1

Frequently asked questions

What does Novel Bio do?
Novel Bio is a US-based contract development and manufacturing organization (CDMO) that produces R&D, High-Quality, and GMP-grade plasmid DNA using optimized E. coli platforms. It serves biotech and pharmaceutical developers working on nucleic acid vaccines, RNA therapeutics, and cell and gene therapies, offering domestic plasmid supply aligned with BIOSECURE Act requirements.
Who are Novel Bio's investors?
Novel Bio's investors include OK Computer.